Paid Clinical Trials in Troy, MI
As of July 2026, 86 paid clinical trials are recruiting in Troy, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Troy offers studies at sites including Corewell Health Beaumont Troy Hospital for conditions such as Atopic Dermatitis, Obesity, Overweight, Alopecia Areata. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Troy
Trials by drug in Troy
Filter results
Newly added in Troy
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
81 clinical trials
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
The PREDICT Registry:
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Top Research Study Locations in Troy
Researchers run research studies in Troy, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Corewell Health Beaumont Troy Hospital | Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Acute Lymphoblastic Leukemia | 14 |
| Arcturus Healthcare , PLC, Troy Internal Medicine Research Division | Obesity, Overweight, Atherosclerotic Cardiovascular Disease (ASCVD) | 9 |
| Revival Research Institute, LLC | Atopic Dermatitis, Alopecia Areata, Chronic Cutaneous Lupus Erythematosus | 9 |
| Hematology Oncology Consultants PC-Troy | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Esophageal Adenocarcinoma | 6 |
| Michigan Institute of Urology-Town Center | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Esophageal Adenocarcinoma | 6 |
| Michigan Institute of Urology | Benign Prostatic Hyperplasia, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Castration-resistant Prostate Cancer | 4 |
| Oakland Medical Center | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Gout | 4 |
| Comprehensive Breast Care | Breast Cancer, DCIS, Ductal Breast Carcinoma In Situ | 3 |
| Oakland Medical Research | Alzheimer Disease, Moderate to Severe Chronic Obstructive Pulmonary Disease, Primary Knee Osteoarthritis | 3 |
| Oakland Medical Research Center | Chronic Obstructive Pulmonary Disease, Cortisol Excess, Hypertension (HTN) | 3 |
| Somerset Skin Centre | Chronic Spontaneous Urticaria (CSU), Cutaneous Squamous Cell Carcinoma (CSCC), Plaque Psoriasis | 3 |
| Arcturus Healthcare, PLC. | Obesity, Overweight, Diabetes Mellitus, Type 2 | 2 |
| Michigan Healthcare Professionals Troy | Locally Advanced Lung Non-Small Cell Carcinoma, Stage I Breast Cancer, Stage IIB Lung Cancer AJCC v8 | 2 |
| Revival Research Institute | Chronic Spontaneous Urticaria (CSU), Non-segmental Vitiligo | 2 |
| Revival Research Institute, Llc Troy | Hidradenitis Suppurativa, Hidradenitis Suppurativa (HS) | 2 |
| Galderma Investigational | Prurigo Nodularis, Atopic Dermatitis | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Arcturus Healthcare - Troy Internal Medicine Research Division | Obesity, Overweight | 1 |
| Arcturus Healthcare, PLC, Troy Internal Medicine Research Division | Type 2 Diabetes | 1 |
| Arcturus Healthcare, Public Limited Company, Troy Internal Medicine Research Division | Obesity or Overweight | 1 |
| Atd002 52001 | Atopic Dermatitis | 1 |
| Atd002 52009 | Atopic Dermatitis | 1 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive | 1 |
| GenesisCare USA - Troy | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| Henry Ford Medical Center - Troy | Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma | 1 |
Active & Upcoming Studies in Troy (2026)
Recruiting trials in Troy grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (25 active studies)
- This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. · Phase 3 · Pfizer
- The Vanguard Study: Testing a New Way to Screen for Cancer · National Cancer Institute (NCI)
Diabetes & metabolic (12 active studies)
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
- A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight · Phase 2 · Boehringer Ingelheim
Cardiovascular (4 active studies)
- An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. · Phase 2 · Novartis Pharmaceuticals
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Neurology & pain (2 active studies)
- A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · Bristol-Myers Squibb
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) · Phase 3 · Bristol-Myers Squibb
Common conditions studied in Troy
- Atopic Dermatitis (7 active studies)
- Obesity (7 active studies)
- Overweight (7 active studies)
- Alopecia Areata (2 active studies)
- Alzheimer Disease (2 active studies)
- Breast Cancer (2 active studies)
Leading research sponsors in Troy
- Eli Lilly and Company
- NRG Oncology
- Pfizer
- Alliance for Clinical Trials in Oncology
- Novartis Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in Troy?
There are approximately 86 recruiting clinical trials in Troy, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Troy pay participants?
Most recruiting trials in Troy compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Troy?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Troy?
The most common conditions under active study in Troy include Atopic Dermatitis (7), Obesity (7), Overweight (7), Alopecia Areata (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Troy?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Troy on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Troy?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Troy?
Recruiting research sites in Troy include Corewell Health Beaumont Troy Hospital, Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Revival Research Institute, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Troy right now?
The largest active categories in Troy are Cancer & tumors (25), Diabetes & metabolic (12), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.